Procoagulant effect of the OKT3 monoclonal antibody: Involvement of tumor necrosis factor
- 1 November 1992
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 42 (5) , 1124-1129
- https://doi.org/10.1038/ki.1992.396
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Induction of thromboses within renal grafts by high-dose prophylactic OKT3The Lancet, 1992
- Coagulation in Renal Diseases: The Role of the Glomerular Hemostasis System and Implications for TherapyPublished by Springer Nature ,1991
- Activation of Coagulation after Administration of Tumor Necrosis Factor to Normal SubjectsNew England Journal of Medicine, 1990
- Systemic Reaction to the Anti–T-Cell Monoclonal Antibody OKT3 in Relation to Serum Levels of Tumor Necrosis Factor and Interferon-αNew England Journal of Medicine, 1989
- RELEASE OF TUMOR NECROSIS FACTOR, INTERLEUKIN-2, AND GAMMA-INTERFERON IN SERUM AFTER INJECTION OF OKT3 MONOCLONAL ANTIBODY IN KIDNEY TRANSPLANT RECIPIENTSTransplantation, 1989
- Effects of cytokines on vascular endothelium: Their role in vascular and immune injuryKidney International, 1989
- Complications and Monitoring of OKT3 TherapyAmerican Journal of Kidney Diseases, 1988
- Modulation of endothelial cell hemostatic properties by tumor necrosis factor.The Journal of Experimental Medicine, 1986
- Increased Factor VIII/von Willebrand Factor Antigen and von Willebrand Factor Activity in Scleroderma and in Raynaud's PhenomenonAnnals of Internal Medicine, 1981
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973